Dupuytren's disease: a localised and accessible human fibrotic disorder

Dupuytren's disease: a localised and accessible human fibrotic disorder

We review the biology of Dupuytren's disease (DD), a common localised fibrotic disorder of the hand. The disease develops through a complex interplay of genetic and environmental factors, and epigenetic signalling. The early-stage disease nodules comprise a complex milieu of stromal and immune...

書誌詳細
主要な著者:	Layton, TB, Williams, L, Nanchahal, J
フォーマット:	Journal article
言語:	English
出版事項:	Cell Press 2022

類似資料

Single cell analysis of the fibrotic landscape in Dupuytren's disease
著者:: Layton, T
出版事項: (2019)

Recent advances in the understanding of Dupuytren's disease
著者:: Nanchahal, J, 等
出版事項: (2019)

Treatment for Dupuytren's disease
著者:: Nanchahal, J, 等
出版事項: (2013)

A vasculature niche orchestrates stromal cell phenotype through PDGF signaling: importance in human fibrotic disease
著者:: Layton, TB, 等
出版事項: (2022)

Tonometry as an outcome measure for the treatment of Dupuytren’s disease.
著者:: Ball, C, 等
出版事項: (2015)

Tonometry as an outcome measure for the treatment of Dupuytren’s disease.
著者:: Ball, C, 等
出版事項: (2016)

Treatments for early-stage Dupuytren’s disease: an evidence-based approach
著者:: Nanchahal, J, 等
出版事項: (2023)

A systematic review of non-surgical treatments for early Dupuytren’s disease
著者:: Ball, C, 等
出版事項: (2015)

Verteporfin ameliorates fibrotic aspects of Dupuytren’s disease nodular fibroblasts irrespective the activation state of the cells
著者:: Nataly Puerta Cavanzo, 等
出版事項: (2022-08-01)

Systematic review of non-surgical treatments for early Dupuytren’s disease
著者:: Ball, C, 等
出版事項: (2016)

Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease.
著者:: Misra, A, 等
出版事項: (2007)

Dupuytren’s disease
著者:: Richard Trèves
出版事項: (2011-09-01)

Dupuytren's disease
著者:: Rames Mattar Junior
出版事項: (2008-03-01)

Myofibroblast distribution in Dupuytren's cords: correlation with digital contracture.
著者:: Verjee, L, 等
出版事項: (2009)

What do we know about managing Dupuytren’s Disease cost-effectively?
著者:: Dritsaki, M, 等
出版事項: (2018)

Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.
著者:: Ball, C, 等
出版事項: (2013)

Method of treating a localized fibrotic disorder using an IL-33 antagonist
著者:: Jagdeep Nanchahal, 等
出版事項: (2018)

What do we know about managing Dupuytren’s disease cost-effectively?
著者:: Melina Dritsaki, 等
出版事項: (2018-01-01)

Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren’s disease: Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD)
著者:: Png, M, 等
出版事項: (2019)

Paediatric Dupuytren's disease
著者:: Pradeoth Mukundan Korambayil, 等
出版事項: (2011-09-01)

Isometric contraction of Dupuytren's myofibroblasts is inhibited by blocking intercellular junctions.
著者:: Verhoekx, J, 等
出版事項: (2013)

Isometric contraction of dupuytren's myofibroblasts is inhibited by blocking intercellular junctions
著者:: Verhoekx, J, 等
出版事項: (2013)

A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren’s disease
著者:: Sophie A. Riesmeijer, 等
出版事項: (2024-01-01)

Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
著者:: Verjee, L, 等
出版事項: (2013)

Unravelling the signalling pathways promoting fibrosis in dupuytren's disease reveals TNF as a therapeutic target
著者:: Verjee, L, 等
出版事項: (2014)

Collagen VI as a driver and disease biomarker in human fibrosis
著者:: Williams, L, 等
出版事項: (2021)

Wnt signaling and Dupuytren's disease.
著者:: Dolmans, G, 等
出版事項: (2011)

The molecular genetics of dupuytren disease
著者:: Ng, M
出版事項: (2018)

Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
著者:: Verjee, L, 等
出版事項: (2010)

Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren’s disease: Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD) [version 2; referees: 2 approved]
著者:: May Ee Png, 等
出版事項: (2019-02-01)

Is Dupuytren’s disease really a “disease of the Vikings”?
著者:: Ng, M, 等
出版事項: (2019)

Guillaume Dupuytren
著者:: Romina A Parquet
出版事項: (2013-01-01)

Sibling recurrence risk in Dupuytren's disease.
著者:: Capstick, R, 等
出版事項: (2013)

Dupuytrens disease–where to from here?
著者:: David B McCombe
出版事項: (2019-03-01)

Epidemiological analysis of patients with Dupuytren's disease
著者:: Henrique Gonçalves Mansur, 等

Surgical treatment results for dupuytren's disease
著者:: Serkan Aykut, 等
出版事項: (2017-06-01)

The Rationale for Treating the Nodule in Dupuytren’s Disease
著者:: Lynn D. Ketchum, MD
出版事項: (2014-12-01)

Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300
著者:: Williams, LM, 等
出版事項: (2020)

Enfermedad de Dupuytren
著者:: J. M. Arandes Renú
出版事項: (2010-11-01)

Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease.
著者:: Helen B Forrester, 等
出版事項: (2013-01-01)